Supriya Lifescience : Insider Trading - Others

Date: November 13, 2022
To,	To,
BSE Limited	National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers	Exchange Plaza, C-1, Block G
Dalal Street,	Bandra Kurla Complex
Mumbai - 400 001	Bandra (E), Mumbai - 400 051
Scrip Code: 543434	Scrip Symbol: SUPRIYA
Dear Sir (s),

Sub:- Reporting under SEBI (Prohibition of Insider Trading) Regulations, 2015 for violation of Company's Insider Trading Policy

This is to inform you that in terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015 ("the SEBI Regulations"), Policy for Trading in the securities of Supriya Lifescience Limited by an Insider' ("the Policy"), and SEBI Circular No. SEBI/HO/ISD/ISD/CIR/P/2020/135 dated July 23, 2020, the details of violation of the Policy by the Designated Persons along with the action taken by the Company thereon is enclosed as "Annexure A" to this letter.

Thanking you,

Yours faithfully,

For Supriya Lifescience Limited

Shweta Singh

Company Secretary & Compliance Officer

Membership No.: A44973

Corporate office	: 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai - 400 063. Maharashtra, India.
	Tel: [phone]	Fax : [phone]	GSTIN: 27AALCS8686A1ZX
	CIN: L51900MH2008PLC180452 E-mail:supriya@supriyalifescience .com Website: www.supriyalifescience.com
Factory	: A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.- Khed, Dist. - Ratnagiri, Pin :415 722, Maharashtra, India.
	Tel: [phone]	Fax: [phone]	E-mail: [e-mail]

GOVT. RECOGNISED EXPORT HOUSE

Annexure A

Report by Supriya Lifescience Limited for violations related to Code of Conduct under SEBI

(Prohibition of Insider Trading) Regulations, 2015.

	Sr. No.		Particulars		Details
1		Name of the listed company/ Intermediary/Fiduciary		Supriya Lifescience Limited

• Please tick appropriate checkbox Reporting in capacity of :  Listed Company

• Intermediary
• Fiduciary

• A. Details of Designated Person (DP)

i.	Name of the DP	Mr. Giju Varghese
ii.	PAN of the DP	ACAPV2013Q
iii.	Designation of DP	Corporate Quality Head - QA
iv.	Functional Role of DP	Corporate Quality Head - QA
v.	Whether DP is Promoter or belongs to Promoter Group	No
B. If Reporting is for immediate relative of DP
i.	Name of the immediate relative of DP	NIL
ii.	PAN of the immediate relative of DP	NIL
C. Details of transaction(s)
i.	Name of the scrip	SUPRIYA
ii. No of shares traded and value (Rs.) (Date- wise)	1. Purchased 80 shares on
		17.10.2022 for Rs. 23,278.80
		during the trading window
		closure.

Corporate office	: 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai - 400 063. Maharashtra, India.
	Tel: [phone]	Fax : [phone]	GSTIN: 27AALCS8686A1ZX
	CIN: L51900MH2008PLC180452 E-mail:supriya@supriyalifescience .com Website: www.supriyalifescience.com
Factory	: A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.- Khed, Dist. - Ratnagiri, Pin :415 722, Maharashtra, India.
	Tel: [phone]	Fax: [phone]	E-mail: [e-mail]

GOVT. RECOGNISED EXPORT HOUSE

			D. In case value of trade(s) is more than Rs.10 lacs in a calendar quarter
			i. Date of intimation of trade(s) by concerned		N.A.
			DP/director/promoter/promoter group to Company
			under regulation 7 of SEBI (PIT) Regulations, 2015
			ii. Date of intimation of trade(s) by Company to stock		N.A.
			exchanges under regulation 7 of SEBI (PIT)
			Regulations, 2015
4		Details of violations observed under Code of Conduct		Trading in shares of the
					Company during the closure of
					Trading window.
5		Action taken by Listed company/ Intermediary/ Fiduciary		Being the first instance of
					violation of Insider Trading code
					by the Designated Person, the
					Audit Committee issued a strict
					warning letter in this behalf to
					the employee to take utmost care
					in future to avoid further
					stringent action.
6		Reasons recorded in writing for taking action stated above		The action stated above was
					taken after considering the fact
					that it was first instance of
					violation on the part of the
					Designated Person and the
					quantum of shares involved
					being non substantial portion.
7		Details of the previous instances of violations, if any, since		N.A.
			last financial year

• If any amount collected for Code of Conduct violation(s)

	i. Mode of transfer to SEBI - IPEF (Online/Demand Draft)	N.A.

Corporate office	: 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai - 400 063. Maharashtra, India.
	Tel: [phone]	Fax : [phone]	GSTIN: 27AALCS8686A1ZX
	CIN: L51900MH2008PLC180452 E-mail:supriya@supriyalifescience .com Website: www.supriyalifescience.com
Factory	: A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.- Khed, Dist. - Ratnagiri, Pin :415 722, Maharashtra, India.
	Tel: [phone]	Fax: [phone]	E-mail: [e-mail]

GOVT. RECOGNISED EXPORT HOUSE

	ii. Details of transfer/payment			N.A.
	In case of Online:
		Particulars	Details
		Name of the transferor
		Bank Name, branch and
		Account number
		UTR/Transaction reference
		Number
		Transaction date
		Transaction Amount (in Rs.)
	In case of Demand Draft (DD):
		Particulars	Details
		Bank Name and branch
		DD Number
		DD date
		DD amount (in Rs.)
9	Any other relevant information			N.A.

For Supriya Lifescience Limited

Shweta Singh

Company Secretary & Compliance Officer

PAN: DPCPS7198K

Email: [e-mail]

Date: 13.11.2022

Place: Mumbai

Corporate office	: 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai - 400 063. Maharashtra, India.
	Tel: [phone]	Fax : [phone]	GSTIN: 27AALCS8686A1ZX
	CIN: L51900MH2008PLC180452 E-mail:supriya@supriyalifescience .com Website: www.supriyalifescience.com
Factory	: A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.- Khed, Dist. - Ratnagiri, Pin :415 722, Maharashtra, India.
	Tel: [phone]	Fax: [phone]	E-mail: [e-mail]

GOVT. RECOGNISED EXPORT HOUSE